our_people1.jpg

Peter Gray

Chairman

  • R
  • N

Peter Gray

Chairman

Peter Gray (61) is Chairman and non-executive director of UDG Healthcare. Peter was appointed Chairman on 7 February 2012, having served as a non-executive director since 28 September 2004. Peter formerly held senior executive positions in a number of Irish public companies, most recently that of Vice Chairman and Chief Executive of ICON plc, the multinational pharmaceutical development services company. Peter is currently also a non-executive director of Jazz Pharmaceuticals plc, and two other private companies.

Peter Gray sits on the following committees:

Brendan-McAtamney.jpg

Brendan McAtamney

Chief Executive

Brendan McAtamney

Chief Executive

Brendan McAtamney (53) became a director of UDG Healthcare on 16 December 2013 and was appointed Chief Executive on 2 February 2016, having originally joined the company in September 2013 as Chief Operating Officer. Previously, Brendan held various senior management positions with Abbott, latterly as Vice President Commercial and Corporate Officer within the Established Pharmaceuticals Division.

Alan-Ralph.jpg

Alan Ralph

Chief Financial Officer

Alan Ralph

Chief Financial Officer

Alan Ralph (46) joined UDG Healthcare in 1999 and was appointed a director on 19 June 2008. Prior to being appointed Chief Financial Officer on 1 June 2013, Alan had responsibility for the Supply Chain Services division. Previously, Alan held various roles throughout the Group including Managing Director of the Pharma Wholesale division and Group Financial Controller. Formerly, Alan worked with Banta Corporation and Price Waterhouse.

Chris-Corbin.jpg

Chris Corbin

MANAGING DIRECTOR ASHFIELD COMMERCIAL & MEDICAL SERVICES

Chris Corbin

MANAGING DIRECTOR ASHFIELD COMMERCIAL & MEDICAL SERVICES

Chris Corbin (59) was appointed a director of UDG Healthcare on 20 June 2003 and is Managing Director of Ashfield Commercial & Medical Services. Chris founded Ashfield Healthcare Limited and previously held sales management positions with Parke Davis, Fisons, Astra and May & Baker. Chris was formerly Patron for SETPOINT Leicestershire, Chairman of Leicestershire Business Awards and a member of Derbyshire Magistrates Bench. 

Chris-Brinsmead.jpg

Chris Brinsmead

Non-Executive Director

  • R
  • R
  • N

Chris Brinsmead

Non-Executive Director

Chris Brinsmead CBE (56) was appointed a non-executive director of UDG Healthcare on 12 April 2010. Chris was formerly Chairman of AstraZeneca Pharmaceuticals UK, President of AstraZeneca UK and Ireland, and President of the Association of the British Pharmaceutical Industry (ABPI). Chris is also a non-executive director of other companies including the Cambian Group plc and the Wesleyan Assurance Society and is a member of council at Imperial College.

Chris Brinsmead sits on the following committees:

Gerard-Van-Odijk.jpg

Gerard Van Odijk

Non-Executive Director

  • A
  • R

Gerard Van Odijk

Non-Executive Director

Gerard van Odijk (57) was appointed a non-executive director of UDG Healthcare on 16 December 2013. Gerard has 25 years’ experience in the European healthcare industry and was formerly President and Chief Executive Officer of Teva Pharmaceuticals Europe. Prior to this, Gerard held various senior management positions with GlaxoSmithKline, latterly holding the position of Senior Vice President and Area Director Northern Europe. Gerard holds a medical degree from the University of Utrecht, is an independent industrial advisor currently serving as a non-executive director of Bavarian Nordic A/S, and was formerly a non-executive director of Alvogen and Chairman of Merus Pharmaceuticals. 

Gerard Van Odijk sits on the following committees:

Lisa-Ricci.jpg

Lisa Ricciardi

Non-Executive Director

  • R
  • R

Lisa Ricciardi

Non-Executive Director

Lisa Ricciardi (55) was appointed a non-executive director of UDG Healthcare on 14 June 2013. Lisa was formerly Senior Vice President of Foundation Medicine, Inc. and prior to this was Senior Vice President of US and International Business Development at Medco Health Solutions. Lisa is also a non-executive director of Chimerix, Inc., was previously a venture partner with Essex Woodlands, and also held a number of senior positions with Pfizer. 

Lisa Ricciardi sits on the following committees:

Linda-Wilding.jpg

Linda Wilding

Non-Executive Director

  • A
  • R

Linda Wilding

Non-Executive Director

Linda Wilding (56) was appointed a non-executive director of UDG Healthcare on 16 December 2013. Linda’s career includes 12 years at Mercury Asset Management where she was Managing Director of the Private Equity division. Prior to this, Linda qualified as a chartered accountant while working with Ernst & Young. Linda is currently Chair of the Valuation Committee at HgCapital Private Equity and HgCapital Renewable Investments, and is a non-executive director of Imperial Innovations Group plc. Linda previously served as Chair of Corin plc, Sanctuary Holdings Limited, Cornish Bakehouse and Pacific Direct Limited, and as a non-executive director of Luminar plc.

Linda Wilding sits on the following committees:

Phil-Toomey.jpg

Philip Toomey

Non-Executive Director

  • A
  • R
  • N

Philip Toomey

Non-Executive Director

Philip Toomey (62) was appointed a non-executive director of UDG Healthcare on 27 February 2008, becoming Senior Independent non-executive director on 14 June 2013. Philip was formerly Global Chief Operating Officer for Accenture’s financial services industry practice. Philip has wide ranging international consulting experience, was a member of the Accenture Global Leadership Council, and is a non-executive director of Kerry Group plc. 

Philip Toomey sits on the following committees:

miller-rich-nancy.jpg

Nancy Miller-Rich

NON-EXECUTIVE DIRECTOR

Nancy Miller-Rich

NON-EXECUTIVE DIRECTOR

Nancy Miller-Rich joins the Board of UDG Healthcare plc as non-executive director. Nancy is Senior Vice-President, Business Development & Licensing, Strategy and Commercial Support for Global Human Health at MSD, known as Merck in the United States and Canada.  With more than thirty years of experience in the healthcare industry, Nancy’s background includes sales, marketing, and business development for MSD, Schering-Plough, Sandoz (now Novartis), and Sterling Drug.

Myles-Lee-April-2017teal.jpg (1)

Myles Lee

Non-executive Director

  • A

Myles Lee

Non-executive Director

Myles Lee was appointed to the Board of UDG Healthcare plc as a non-executive director with effect from 1 April 2017. Myles was Group Chief Executive, and before that Finance Director, of CRH plc, a FTSE100 and Fortune 500 company, prior to retiring in December 2013. With more than thirty years’ experience at senior financial and managerial level, Myles has extensive global experience in management, M&A and finance. He is a qualified civil engineer and a Fellow of the Institute of Chartered Accountants in Ireland. Myles also currently serves on the Board of Ingersoll Rand Inc, a Fortune 500 company and Babcock International Group plc, a FTSE100 company.

Myles Lee sits on the following committees: